Molecule Holdings (XCNQ:MLCL) ROE % Adjusted to Book Value: 0.00% (As of Jul. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Molecule Holdings ROE % Adjusted to Book Value?

Molecule Holdings XCNQ:MLCL ROE % Adjusted to Book Value is 0.00% as of Jul. 2023.

Molecule Holdings's ROE % for the quarter that ended in Jul. 2023 was 0.00%. Molecule Holdings's PB Ratio for the quarter that ended in Jul. 2023 was N/A. Molecule Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2023 was N/A.

Molecule Holdings ROE % Adjusted to Book Value Related Terms

Molecule Holdings ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Molecule Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecule Holdings ROE % Adjusted to Book Value Chart

Molecule Holdings Annual Data
Trend Oct19 Oct20 Oct21 Oct22
ROE % Adjusted to Book Value
0.00 -40.28 -24.21 0.00

Molecule Holdings Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XCNQ:MLCL vs ZTS: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Molecule Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Molecule Holdings ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Molecule Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Molecule Holdings's ROE % Adjusted to Book Value falls into.


Molecule Holdings ROE % Adjusted to Book Value Calculation

Molecule Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Oct. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

Molecule Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jul. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 0.00% mean?
Molecule Holdings (XCNQ:MLCL) has a ROE % Adjusted to Book Value of 0.00% as of Jul. 2023. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Molecule Holdings and its competitors.
Is Molecule Holdings' ROE % Adjusted to Book Value too high?
Molecule Holdings' current ROE % Adjusted to Book Value is 0.00%.
How does Molecule Holdings' ROE % Adjusted to Book Value compare to ZTS?
Molecule Holdings' ROE % Adjusted to Book Value of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Molecule Holdings and its competitors. Molecule Holdings's current ROE % Adjusted to Book Value is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecule Holdings stock overvalued right now?
Molecule Holdings (XCNQ:MLCL) has a current ROE % Adjusted to Book Value of 0.00%. The current ROE % Adjusted to Book Value is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Molecule Holdings (XCNQ:MLCL), the current ROE % Adjusted to Book Value is 0.00% as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecule Holdings Business Description

Address 591 Reynolds Road, Landsdowne, ON, CAN, K0E 1L0
Molecule Holdings Inc is a licensed cannabis beverage company. It is engaged in the production, packaging, and distribution of beverages related to cannabis.